MARKET

GALT

GALT

Galectin Thera
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.840
-0.040
-1.39%
Closed 16:00 01/24 EST
OPEN
2.860
PREV CLOSE
2.880
HIGH
2.895
LOW
2.810
VOLUME
144.51K
TURNOVER
--
52 WEEK HIGH
6.06
52 WEEK LOW
2.720
MARKET CAP
161.27M
P/E (TTM)
-7.2045
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GALT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GALT News

  • Comcast -1.2% as UBS sees investments weighing growth
  • Seeking Alpha - Article.1d ago
  • Here are the biggest analyst calls of the day: Alphabet, Apple, PayPal, Intel & more
  • CNBC.com.1d ago
  • ClearBridge Multi Cap Growth Strategy Portfolio Manager Commentary Q4 2019
  • Seeking Alpha - Article.2d ago
  • Wall Street Breakfast: Last Day In Davos
  • Seeking Alpha - Article.2d ago

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About GALT

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally occurring, readily-available plant materials as starting material in manufacturing processes to create complex carbohydrates with specific molecular weights and other pharmaceutical properties. The Company has two product candidates, GR-MD-02 and GM-CT-01. The Company's galectin-3 inhibitor is GR-MD-02. The Company is focusing on development of GR-MD-02 intended to be used in the treatment of liver fibrosis associated with fatty liver disease (NASH), moderate to severe plaque psoriasis and in cancer therapy in combination with immune-system modifying agent(s). GM-CT-01 is a compound that continues to be explored in preclinical studies.
More

Webull offers Galectin Therapeutics Inc (GALT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.